PCN12 Dasatinib or Imatinib in Newly Diagnosed Chronic Myeloid Leukemia Patientes in the Chronic Phase- Five-Years Follow-up Simulated Cohort
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1113
https://www.valueinhealthjournal.com/article/S1098-3015(11)02675-1/fulltext
Title :
PCN12 Dasatinib or Imatinib in Newly Diagnosed Chronic Myeloid Leukemia Patientes in the Chronic Phase- Five-Years Follow-up Simulated Cohort
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02675-1&doi=10.1016/j.jval.2011.08.1113
First page :
A435
Section Title :
Cancer
Open access? :
No
Section Order :
1070